PPCB · Propanc Biopharma, Inc. · Shareholders & Ownership
Substantial doubt about the company's ability to continue as a going concern.
“These matters raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-K filed Sep 25, 2026
Every disclosed holder of PPCB in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.
Who Owns PPCB
13F quarter Jun 30, 2026| Holder group | Shares | % Out |
|---|---|---|
| Institutional (13F) | 47,884 | 0.76% |
| Insiders (Forms 3, 4, 5) | 0 | 0.00% |
| 13D/G-only blocks | 0 | 0.00% |
| Remaining | 6,283,232 | 99.24% |
| Registered funds (N-PORT, not summed) | 0 | 0.00% |
Shares outstanding: 6,331,116, the issuer's latest cover-page count restated onto today's split basis.
13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.
Holders of PPCB
| # | Holder | Shares | As of | Notes |
|---|---|---|---|---|
| 1 |
JANE STREET GROUP, LLC
13F
CIK 1595888 · Unknown · Jun 30, 2026
|
25,550 | ||
| 2 |
CITADEL ADVISORS LLC
13F
CIK 1423053 · Registered investment adviser · Jun 30, 2026
|
12,090 | ||
| 3 |
HRT FINANCIAL LP
13F
CIK 1475597 · Unknown · Jun 30, 2026
|
10,242 | ||
| 4 |
Caitong International Asset Management Co., Ltd
13F
CIK 1963355 · Unknown · Jun 30, 2026
|
2 |
Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.